Sr. Medical Science Liaison - Philadelphia, PA, United States - Glaukos

Description

Job Description We are a medical technology and pharmaceutical company that's advancing the treatment of ophthalmic diseases. At Glaukos, we are pioneering new treatments for chronic eye diseases and are focused on novel therapies for the treatment of glaucoma (market-leader iStent inject W), corneal disorders and retinal diseases. We have an amazing culture that fosters opportunities for growth, excellent benefits, great pay, and are Great Place to Work Certified. We're looking for a Medical Science Liaison (MSL) to join our team. This is an opportunity to be part of a team that takes pride in leading the way in our business and our community - we dare to dream, dare to lead, and dare to care. If you want to be part of this exciting work, you belong at Glaukos How Will You Make an Impact? The Medical Science Liaison (MSL) Team plays an important role in Global Medical Affairs at Glaukos, being part of a field-based team of medical/clinical scientific experts, who engage in compliant scientific discussions with Key Opinion Leaders (KOLs) on disease state, practice education and product education. What Will You Do?

• The MSL will be expected to develop new relationships with customers across assigned geographies.
• The Sr. MSL will also support the hiring and coaching of future MSLs as well as developing innovative processes, infrastructure, and capabilities to best serve our customers.
• Solid understanding of the roles and responsibilities of US Medical Science Liaisons and a knowledge base of eye diseases.
• Maintain and demonstrate thorough and up-to-date knowledge of disease state, study methodology, clinical information, and diagnostic data.
• Execute on approved medical platforms/strategies and MSL initiatives.
• Technical/scientific subject matter resource to cross functional partners.
• Teach, coach and mentor new or less experienced MSLs; assume responsibility for special projects.
• Diagnostic expertise and strategic planning.
• Understand patient diagnostics recommendations/guidelines/approvals.
• Guide and motivate team members without a direct reporting relationship.

Key Responsibilities Include But Not Limited To:

• Identify and manage Key Opinion Leaders (KOL) optometrists and ophthalmologists.
• Expert in the field by communicating relevant medical and scientific information.
• Obtain and provide actionable insights that enhance the value and appropriate use of Glaukos' products.
• Establish KOL engagements and attend scientific sessions at local, regional, and national conference meetings.
• Support development of clinical evidence studies.
• Maintain expertise in disease state management, emerging therapies, and the competitive landscape.
• Liaise with local and regional optometric and ophthalmic medical societies.
• Provide whole practice education to optometric and ophthalmic centers.
• Manage territory budget, metrics, KOL mapping and CRM entries.
• Support cross-functional collaboration including clinical operations, market access, sales, and marketing.

How Will You Get There?

• Doctorate degree (OD, PharmD, PhD, MD, DO).
• 8+ years of experience as a medical science liaison in eye care.
• Navigate systems and processes including Microsoft Office and customer relationship management software and be self-motivated.
• Provides, guides, and uses professional concepts in developing resolution to critical issues.
• Provides insight in the development of Company goals and ideals.
• Identify goals and approaches to critical assignments.
• Creates formal networks with both internal and external community.
• The position will be field based (remote) in the West Coast of United States and employee must live within commuting distance to a major airport.
• This position reports directly to our Vice President, Global Medical Affairs.
• Travel to conferences, field-visits nationally, and our corporate headquarters will be required, estimated up to70%.

Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible. These are just a few of the terms our employees use to describe their experiences as a part of the Glaukos family. Those may seem like big aspirations, but here at Glaukos, we recognize the deep significance and profound meaning that comes from knowing that we can make a meaningful difference by helping improve eyesight of people worldwide. And because we're a rapidly growing company with a dynamic, fast-paced culture, individual employees are empowered with more diverse and enriching challenges that might not be possible at a larger company, and more fulfillment in knowing every person and every task is directly tied to making a difference in the life of others. We offer competitive salary (based on experience), bonus eligibility, medical/dental/vision, life insurance, stock options, 401(k) Employer Match, Employee Stock Purchase Program, generous time off & paid holidays as well as time-off to volunteer in the community, plus the opportunity to work for a company that is pioneering a new glaucoma treatment class Moreover, Glaukos Corporation has been Certified as a Great Place to Work the last two years Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law. About Us Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

Our company was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma. In 2012, we launched our first MIGS device-the iStent-in the United States, followed by our next-generation iStent inject device in September 2018 and iStent inject W in September 2020.

In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies for glaucoma, corneal health, and retinal diseases.

Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol "GKOS". Our global headquarters is located in San Clemente, California with additional locations in Waltham and Burlington, Massachusetts. Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employmentwithout regard to race, color, religion, sex including sexual orientation and genderidentity, national origin, disability, protected Veteran Status, or any othercharacteristic protected by applicable federal, state, or local law.
#J-18808-Ljbffr